Jed N. Hassinger

Statistics

Publications

Citations

697

H-Index

Active since

2006

Affiliations

Sarepta Therapeutics (United States)(Current)

Oregon State University

Jed N. Hassinger is an author at Sarepta Therapeutics (United States) specializing in peptide conjugates, morpholino oligonucleotides, and morpholino oligomers.

Publications per year

2006–2009

Publications

Pharmacokinetics, Biodistribution, Stability and Toxicity of a Cell-Penetrating Peptide−Morpholino Oligomer Conjugate

Adams Amantana, Hong M. Moulton, Melissa L. Cate et al. · Bioconjugate Chemistry · 2007 · 206 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Stability of Cell-Penetrating Peptide−Morpholino Oligomer Conjugates in Human Serum and in Cells

Derek S. Youngblood, Susie A. Hatlevig, Jed N. Hassinger et al. · Bioconjugate Chemistry · 2006 · 180 citations

Pharmacy, Biochemistry, Pharmaceutics +17

Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity

Rebecca P. Wu, Derek S. Youngblood, Jed N. Hassinger et al. · Nucleic Acids Research · 2007 · 119 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Gene-Specific Effects of Antisense Phosphorodiamidate Morpholino Oligomer-Peptide Conjugates on<i>Escherichia coli</i>and<i>Salmonella enterica</i>Serovar Typhimurium in Pure Culture and inTissue Culture

Lucas D. Tilley, Orion S. Hine, J. Kellogg et al. · Antimicrobial Agents and Chemotherapy · 2006 · 70 citations · Full text

Life Sciences, Microbiology, Molecular Biology +16

Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection

Dana L. Swenson, Kelly L. Warfield, Travis K. Warren et al. · Antimicrobial Agents and Chemotherapy · 2009 · 70 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

1–5 of 6